| Literature DB >> 35024185 |
Daisy Sotero Chacon1, Taffarel Melo Torres2, Ivanice Bezerra da Silva1, Thiago Ferreira de Araújo1, Alan de Araújo Roque3, Francisco Ayrton Senna Domingos Pinheiro1, Denise Selegato4, Alan Pilon5, Fernanda Priscila Santos Reginaldo1, Cibele Tesser da Costa6, Johnatan Vilasboa6, Rafael Teixeira Freire7, Eduardo Luiz Voigt8, José Angelo Silveira Zuanazzi9, Renata Libonati10, Julia Abrantes Rodrigues10, Filippe Lemos Maia Santos10, Kátia Castanho Scortecci8, Norberto Peporine Lopes5, Leandro De Santis Ferreira1, Leandro Vieira Dos Santos11, Alberto José Cavalheiro12, Arthur Germano Fett-Neto6, Raquel Brandt Giordani1.
Abstract
Introduction: Natural products of pharmaceutical interest often do not reach the drug market due to the associated low yields and difficult extraction. Knowledge of biosynthetic pathways is a key element in the development of biotechnological strategies for plant specialized metabolite production. Erythrina species are mainly used as central nervous system depressants in folk medicine and are important sources of bioactive tetracyclic benzylisoquinoline alkaloids (BIAs), which can act on several pathology-related biological targets.Entities:
Keywords: Benzylisoquinoline Alkaloids; Caatinga; Erythrina velutina; Targeted metabolite profile; Transcriptome
Mesh:
Substances:
Year: 2021 PMID: 35024185 PMCID: PMC8655131 DOI: 10.1016/j.jare.2021.01.017
Source DB: PubMed Journal: J Adv Res ISSN: 2090-1224 Impact factor: 10.479
Identification and location of collection sites.
| Pool set | Pools | Harvest site | Geographical coordinates | |
|---|---|---|---|---|
| Seeds | Leaves | |||
| A | p1 | p5 | Jardim do Seridó I | 6°33′58.2″S 36°43′00.6″W |
| B | p2 | p6 | Acari I | 6°27′44.5″S 36°38′30.6″W |
| C | p3 | p7 | Acari II | 6°28′19.5″S 36°38′32.5″W |
| D | p4 | p8 | Jardim do Seridó II | 6°33′48.6″S 36°43′11.0″W |
Fig. 5Experimental strategy and integration of omic analyzes. Prospecting bioactive compounds from biodiversity is a challenging task, and the tools that can most adequately assist in this process become increasingly important. Data integration contributes to a better understanding of the biological system being examined, leading to more detailed understanding of target compound production by the organs of the plant growing in its natural habitat.
Fig. 1Overview of Erythrina velutina alkaloids by plant structure (leaves and seeds) and presence in cluster 1 and 2.
Fig. 2Molecular networking and annotated alkaloids. (A) Representation of the tetracyclic spiroamine of the alkaloids of the genus Erythrina and their respective classes (B) Molecular networking with MS/MS data from hydroethanolic crude extracts analysis of Erythrina velutina. Green nodes: alkaloids exclusively in leaves; orange nodes: alkaloids exclusively in seeds; blue nodes: alkaloids in both leaves and seeds, and gray nodes (leaves: pentagon, seeds: square): alkaloids identified but not annotated (they did not match fully the mass spectrum of alkaloids previously reported in Erythrina spp.). The high resolution mass value for each alkaloid is shown in the node. Thicker and closer lines indicate greater similarity between the chemical entities. (*) highlight the mass values that were repeated in the cluster (may represent isomers). Red-bordered nodes indicate glycosylated alkaloids. Clusters 1 and 2 are not related to the division of categories of the dienoid and alkenoid classes. (C) Structures and characteristic losses due to substituent elimination observed in dienoid subclass fragmentation that were also present in MS/MS spectra of the alkaloids annotated in cluster 1.
Fig. 4Gene expression heatmap. The transcriptional expression profile of the candidate genes involved in the Erythrina alkaloid biosynthesis pathway is illustrated by a color gradient. All transcript expression values were scaled by TPM between low and high expression. (A) Orange different color gradients indicate low or high number of transcripts in each identified pool after annotation by domain; Palette with different color gradients in blue indicate the low or high expressed transcripts. Transcripts considered as possible isoforms were identified and named as “like”. Heatmap in green and orange box indicate transcripts identified exclusively in leaves and seeds, while in blue box, found in both plant structures. (B) Structure of the glycosylated alkaloids identified in the metabolic profile. (C) Heatmap of transcripts selected by domain with catalytic glycosylation function and subsequently identified using Blastx in seeds and leaves (UDP-glycosyltransferase). (D) Heatmap of the number of transcripts identified with the UDP-glycosyltransferase domain. P1-p4: transcripts expressed in seeds and p5-p8: transcripts expressed in leaves.
Fig. 3Putative biosynthetic pathway of Erythrina alkaloids. Erythrina alkaloids are isoquinoline-type, forming a component of the phenylalanine precursor. The pathway begins with branches initiated with 4-HPP and tyrosine, which by enzymatic action form 4-HPAA and dopamine, respectively, producing intermediate (s)-norcoclaurine and coclaurine. The CYP80B3 part (S)-methylnorlaudanosoline will be formed and is one of the crucial points in the chemical cascade of Erythrina alkaloids, as part of it may generate a bifurcation to (S)-norreticuline (pathways in green) and norprotosinomenine (pathways in pink). Pathways in yellow color represent the alkaloids annotated in this study (in accordance with Table S1); Dotted arrows indicate reactions not yet fully established; Blue transcripts were identified in our transcriptome data set according to the Blastx result. Structures of the seven glycosylated alkaloids [11], [12], [15], [19], [20], [21], [22] are shown in Fig. 4. Abbreviations: 4-HPP, 4-Hydroxyphenylpyruvate; 4-HPAA, 4-hydroxyphenylacetaldehyde; TYDC, TYROSINE/DOPA DECARBOXYLASE; TAT, TYROSINE AMINOTRANSFERASE; NCS, NORCOCLAURINE SYNTHASE; 6OMT, (S)-NORCOCLAURINE 6-O-METHYLTRANSFERASE; 7OMT, (R,S)-RETICULINE 7-O-METHYLTRANSFERASE; CYP80B3, (S)-N-METHYLCOCLAURINE 3′-HYDROXYLASE; 4OMT, 3′-HYDROXY-N-METHYL-(S)-COCLAURINE 4′-O-METHYLTRANSFERASE; N4OMT, NORBELLADINE 4′-O-METHYLTRANSFERASE; CNMT, (S)-COCLAURINE N-METHYLTRANSFERASE; BBE, BERBERINE BRIDGE ENZYME; CYP719B1, SALUTARIDINE SYNTHASE; CYP712A2, (S)-STYLOPINE SYNTHASE; SALR, SALUTARIDINE REDUCTASE; SALAT, SALUTARIDINOL 7-O-ACETYLTRANSFERASE; CYP96T1, NOROXOMARITIDINE SYNTHASE; T6ODM, THEBAINE 6-O-DEMETHYLASE; COR, NADPH-DEPENDENT CODEINONE REDUCTASE; SARED, SANGUINARINE REDUCTASE.